Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 168, 33-48
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81371014, 81470639, 81670861)
- Shanghai Science and Technology Committee (16411961900, 17140903000)
This publication has 58 references indexed in Scilit:
- Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of GlaucomaPLOS ONE, 2012
- Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma modelCell Death & Disease, 2012
- Hydrogen Sulfide Protects the Retina from Light-induced Degeneration by the Modulation of Ca2+ InfluxJournal of Biological Chemistry, 2011
- Stem cell therapy for glaucoma: possibilities and practicalitiesExpert Review of Ophthalmology, 2011
- Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerveExperimental Eye Research, 2010
- Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cellsNeurochemistry International, 2010
- Inactivation of astroglial NF‐κB promotes survival of retinal neurons following ischemic injuryEuropean Journal of Neuroscience, 2009
- Hydrogen sulfide: Neurochemistry and neurobiologyNeurochemistry International, 2008
- Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene DosagePLOS Genetics, 2005
- Retinal OxygenArchives of Ophthalmology (1950), 2003